Judith A. Pratt - Publications

University of Strathclyde, Glasgow, Scotland, United Kingdom 

63 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mitchell EJ, Thomson DM, Openshaw RL, Bristow GC, Dawson N, Pratt JA, Morris BJ. Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions. Scientific Reports. 10: 12303. PMID 32704009 DOI: 10.1038/S41598-020-69130-8  0.322
2020 Mitchell EJ, Brett RR, Armstrong JD, Sillito RR, Pratt JA. Temporal dissociation of phencyclidine: Induced locomotor and social alterations in rats using an automated homecage monitoring system - implications for the 3Rs and preclinical drug discovery. Journal of Psychopharmacology (Oxford, England). 269881120920455. PMID 32438848 DOI: 10.1177/0269881120920455  0.304
2020 Bristow GC, Thomson DM, Openshaw RL, Mitchell EJ, Pratt JA, Dawson N, Morris BJ. 16p11 Duplication Disrupts Hippocampal-Orbitofrontal-Amygdala Connectivity, Revealing a Neural Circuit Endophenotype for Schizophrenia. Cell Reports. 31: 107536. PMID 32320645 DOI: 10.1016/J.Celrep.2020.107536  0.4
2019 Openshaw RL, Thomson DM, Thompson R, Penninger JM, Pratt JA, Morris BJ, Dawson N. Map2k7 Haploinsufficiency Induces Brain Imaging Endophenotypes and Behavioral Phenotypes Relevant to Schizophrenia. Schizophrenia Bulletin. PMID 31219577 DOI: 10.1093/Schbul/Sbz044  0.404
2019 Openshaw RL, Kwon J, McColl A, Penninger JM, Cavanagh J, Pratt JA, Morris BJ. JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk. Journal of Neuroinflammation. 16: 18. PMID 30691477 DOI: 10.1186/S12974-019-1408-5  0.303
2018 Kouskou M, Thomson DM, Brett RR, Wheeler L, Tate RJ, Pratt JA, Chamberlain LH. Disruption of the Zdhhc9 intellectual disability gene leads to behavioural abnormalities in a mouse model. Experimental Neurology. PMID 29944857 DOI: 10.1016/J.Expneurol.2018.06.014  0.311
2018 Pratt JA, Morris B, Dawson N. Deconstructing Schizophrenia: Advances in Preclinical Models for Biomarker Identification. Current Topics in Behavioral Neurosciences. PMID 29721851 DOI: 10.1007/7854_2018_48  0.386
2018 Bristow G, Thomson D, Pratt J, Morris B, Dawson N. F41. Schizophrenia-Relevant Alterations In Cerebral Metabolism, Glutamate And Monoaminergic Neurotransmitter System Function In A Mouse Model Of 16P11.2 Duplication Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby017.572  0.348
2016 Openshaw RL, Thomson DM, Penninger JM, Pratt JA, Morris BJ. Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline. Psychopharmacology. PMID 27774567 DOI: 10.1007/S00213-016-4463-Y  0.316
2016 Pratt J, Dawson N, Morris BJ, Grent-'t-Jong T, Roux F, Uhlhaas PJ. Thalamo-cortical communication, glutamatergic neurotransmission and neural oscillations: A unique window into the origins of ScZ? Schizophrenia Research. PMID 27317361 DOI: 10.1016/J.Schres.2016.05.013  0.352
2015 Dawson N, Kurihara M, Thomson DM, Winchester CL, McVie A, Hedde JR, Randall AD, Shen S, Seymour PA, Hughes ZA, Dunlop J, Brown JT, Brandon NJ, Morris BJ, Pratt JA. Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1. Translational Psychiatry. 5: e569. PMID 25989143 DOI: 10.1038/Tp.2015.60  0.37
2015 Pratt J. Schizophrenia in the 21st century: new insights and translation into improved therapies. Journal of Psychopharmacology (Oxford, England). 29: 83-4. PMID 25650373 DOI: 10.1177/0269881114566743  0.382
2015 Pratt JA, Morris BJ. The thalamic reticular nucleus: a functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery. Journal of Psychopharmacology (Oxford, England). 29: 127-37. PMID 25586397 DOI: 10.1177/0269881114565805  0.402
2015 Dawson N, Morris BJ, Pratt JA. Functional brain connectivity phenotypes for schizophrenia drug discovery. Journal of Psychopharmacology (Oxford, England). 29: 169-77. PMID 25567554 DOI: 10.1177/0269881114563635  0.407
2014 Morris BJ, Pratt JA. Novel treatment strategies for schizophrenia from improved understanding of genetic risk. Clinical Genetics. 86: 401-11. PMID 25142969 DOI: 10.1111/Cge.12485  0.347
2014 Winchester CL, Pratt JA, Morris BJ. Risk genes for schizophrenia: translational opportunities for drug discovery. Pharmacology & Therapeutics. 143: 34-50. PMID 24561132 DOI: 10.1016/J.Pharmthera.2014.02.003  0.377
2014 Dawson N, McDonald M, Higham DJ, Morris BJ, Pratt JA. Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1786-98. PMID 24492765 DOI: 10.1038/Npp.2014.26  0.438
2014 Dawson N, Xiao X, McDonald M, Higham DJ, Morris BJ, Pratt JA. Sustained NMDA receptor hypofunction induces compromised neural systems integration and schizophrenia-like alterations in functional brain networks. Cerebral Cortex (New York, N.Y. : 1991). 24: 452-64. PMID 23081884 DOI: 10.1093/Cercor/Bhs322  0.419
2013 Ewing SG, Porr B, Pratt JA. Deep brain stimulation of the mediodorsal thalamic nucleus yields increases in the expression of zif-268 but not c-fos in the frontal cortex. Journal of Chemical Neuroanatomy. 52: 20-4. PMID 23660497 DOI: 10.1016/J.Jchemneu.2013.04.002  0.335
2013 Dawson N, Morris BJ, Pratt JA. Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems. Schizophrenia Bulletin. 39: 366-77. PMID 22114100 DOI: 10.1093/Schbul/Sbr144  0.44
2012 Winchester CL, Ohzeki H, Vouyiouklis DA, Thompson R, Penninger JM, Yamagami K, Norrie JD, Hunter R, Pratt JA, Morris BJ. Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia. Human Molecular Genetics. 21: 4910-21. PMID 22899651 DOI: 10.1093/Hmg/Dds331  0.403
2012 Pratt J, Winchester C, Dawson N, Morris B. Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. Nature Reviews. Drug Discovery. 11: 560-79. PMID 22722532 DOI: 10.1038/Nrd3649  0.368
2012 Steward LJ, Kennedy MD, Morris BJ, Pratt JA. Chronic phencyclidine (PCP)-induced modulation of muscarinic receptor mRNAs in rat brain: impact of antipsychotic drug treatment. Neuropharmacology. 62: 1554-63. PMID 21640736 DOI: 10.1016/J.Neuropharm.2011.05.016  0.387
2012 Dawson N, Thompson RJ, McVie A, Thomson DM, Morris BJ, Pratt JA. Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity. Schizophrenia Bulletin. 38: 457-74. PMID 20810469 DOI: 10.1093/Schbul/Sbq090  0.394
2012 Lee G, Thomson DM, McVie A, Suckling CJ, Morris BJ, Pratt JA. Poster #128 NITRIC OXIDE SYNTHASE ACTIVITY IS DIFFERENTIALLY ALTERED BETWEEN ACUTE AND SUBCHRONIC PHENCYCLIDINE TREATMENTS IN DISCRETE MOUSE BRAIN REGIONS Schizophrenia Research. 136: S137-S138. DOI: 10.1016/S0920-9964(12)70442-5  0.467
2012 Dawson N, Thomson DM, Morris BJ, Pratt JA. Poster #14 NEURAL SYSTEMS UNDERLYING SCHIZOPHRENIA-RELATED BEHAVIOURAL PHENOTYPES IN MICE Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70330-4  0.349
2011 Sousa VC, Assaife-Lopes N, Ribeiro JA, Pratt JA, Brett RR, Sebastião AM. Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 472-87. PMID 20927050 DOI: 10.1038/Npp.2010.179  0.33
2011 Thomson DM, McVie A, Morris BJ, Pratt JA. Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine. Psychopharmacology. 213: 681-95. PMID 20878519 DOI: 10.1007/S00213-010-2020-7  0.414
2010 Pratt JA, Dawson N, Winchester CL, Thomson DM, Morris BJ. Distinct Aspects Of Prefrontal Cortex Dysfunction In Schizophrenia Modelled By Acute And Repeated Pcp Treatment: Impact Of Modafinil Schizophrenia Research. 117: 509-509. DOI: 10.1016/J.Schres.2010.02.972  0.381
2010 Dawson N, Higham D, Pratt J, Morris B. Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia Schizophrenia Research. 117: 234-235. DOI: 10.1016/J.Schres.2010.02.349  0.399
2008 Egerton A, Reid L, McGregor S, Cochran SM, Morris BJ, Pratt JA. Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology. 198: 37-49. PMID 18427784 DOI: 10.1007/S00213-008-1071-5  0.378
2008 Pratt JA, Winchester C, Egerton A, Cochran SM, Morris BJ. Modelling prefrontal cortex deficits in schizophrenia: implications for treatment. British Journal of Pharmacology. 153: S465-70. PMID 18311160 DOI: 10.1038/Bjp.2008.24  0.442
2008 Winchester C, Thomson D, Morris B, Pratt J. Alternative Approach To Modulating Schizophrenia-Associated Genes In The Rodent Brain Schizophrenia Research. 102: 67. DOI: 10.1016/S0920-9964(08)70208-1  0.369
2007 Suckling CJ, Murphy JA, Khalaf AI, Zhou SZ, Lizos DE, van Nhien AN, Yasumatsu H, McVie A, Young LC, McCraw C, Waterman PG, Morris BJ, Pratt JA, Harvey AL. M4 agonists/5HT7 antagonists with potential as antischizophrenic drugs: serominic compounds. Bioorganic & Medicinal Chemistry Letters. 17: 2649-55. PMID 17317171 DOI: 10.1016/J.Bmcl.2007.01.093  0.363
2006 Egerton A, Allison C, Brett RR, Pratt JA. Cannabinoids and prefrontal cortical function: insights from preclinical studies. Neuroscience and Biobehavioral Reviews. 30: 680-95. PMID 16574226 DOI: 10.1016/J.Neubiorev.2005.12.002  0.333
2006 Paterson GJ, Ohashi Y, Reynolds GP, Pratt JA, Morris BJ. Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs. Journal of Psychopharmacology (Oxford, England). 20: 636-42. PMID 16478754 DOI: 10.1177/0269881106062025  0.366
2005 Egerton A, Brett RR, Pratt JA. Acute delta9-tetrahydrocannabinol-induced deficits in reversal learning: neural correlates of affective inflexibility. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1895-905. PMID 15812570 DOI: 10.1038/Sj.Npp.1300715  0.358
2005 Allison C, Pratt JA, Ripley TL, Stephens DN. alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate receptor autoradiography in mouse brain after single and repeated withdrawal from diazepam. The European Journal of Neuroscience. 21: 1045-56. PMID 15787709 DOI: 10.1111/J.1460-9568.2005.03902.X  0.359
2005 Egerton A, Reid L, McKerchar CE, Morris BJ, Pratt JA. Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia. Psychopharmacology. 179: 77-84. PMID 15682304 DOI: 10.1007/S00213-004-2109-Y  0.387
2005 Morris BJ, Cochran SM, Pratt JA. PCP: from pharmacology to modelling schizophrenia. Current Opinion in Pharmacology. 5: 101-6. PMID 15661633 DOI: 10.1016/J.Coph.2004.08.008  0.425
2005 Reynolds LM, Cochran SM, Morris BJ, Pratt JA, Reynolds GP. Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain. Schizophrenia Research. 73: 147-52. PMID 15653257 DOI: 10.1016/J.Schres.2004.02.003  0.416
2004 Steward LJ, Kennedy MD, Morris BJ, Pratt JA. The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors. Neuropharmacology. 47: 527-37. PMID 15380371 DOI: 10.1016/J.Neuropharm.2004.04.020  0.421
2003 Allison C, Pratt JA. Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacology & Therapeutics. 98: 171-95. PMID 12725868 DOI: 10.1016/S0163-7258(03)00029-9  0.333
2003 Cochran SM, Kennedy M, McKerchar CE, Steward LJ, Pratt JA, Morris BJ. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 265-75. PMID 12589379 DOI: 10.1038/Sj.Npp.1300031  0.319
2002 Cochran SM, Fujimura M, Morris BJ, Pratt JA. Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse (New York, N.Y.). 46: 206-14. PMID 12325047 DOI: 10.1002/Syn.10126  0.395
2002 Cochran SM, McKerchar CE, Morris BJ, Pratt JA. Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol. Neuropharmacology. 43: 394-407. PMID 12243769 DOI: 10.1016/S0028-3908(02)00091-6  0.393
2002 Gholamreza P, Pratt JA, Nima D. Effects of low-dose scopolamine on locomotor activity: No dissociation between cognitive and non-cognitive effects Neuroscience Research Communications. 31: 165-174. DOI: 10.1002/Nrc.10049  0.315
2001 Brett R, MacKenzie F, Pratt J. Δ9-tetrahydrocannabinol-induced alterations in limbic system glucose use in the rat Neuroreport. 12: 3573-3577. PMID 11733714 DOI: 10.1097/00001756-200111160-00040  0.326
2001 Cochran SM, Harvey AL, Pratt JA. Regionally selective alterations in local cerebral glucose utilization evoked by charybdotoxin, a blocker of central voltage-activated K+-channels. The European Journal of Neuroscience. 14: 1455-63. PMID 11722607 DOI: 10.1046/J.0953-816X.2001.01770.X  0.349
2000 Kempsill FE, Pratt JA. Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine. British Journal of Pharmacology. 131: 997-1003. PMID 11053222 DOI: 10.1038/Sj.Bjp.0703560  0.321
1999 Gray A, Allison C, Pratt JA. A role for AMPA/kainate receptors in conditioned place preference induced by diazepam in the rat. Neuroscience Letters. 268: 127-30. PMID 10406021 DOI: 10.1016/S0304-3940(99)00371-7  0.341
1998 Harvey AL, Bradley KN, Cochran SA, Rowan EG, Pratt JA, Quillfeldt JA, Jerusalinsky DA. What can toxins tell us for drug discovery? Toxicon : Official Journal of the International Society On Toxinology. 36: 1635-40. PMID 9792180 DOI: 10.1016/S0041-0101(98)00156-1  0.338
1998 Pratt JA, Brett RR, Laurie DJ. Benzodiazepine dependence: from neural circuits to gene expression. Pharmacology, Biochemistry, and Behavior. 59: 925-34. PMID 9586850 DOI: 10.1016/S0091-3057(97)00539-X  0.364
1995 Brett RR, Pratt JA. Changes in benzodiazepine-GABA receptor coupling in an accumbens-habenula circuit after chronic diazepam treatment. British Journal of Pharmacology. 116: 2375-84. PMID 8581272 DOI: 10.1111/J.1476-5381.1995.Tb15083.X  0.32
1995 French N, Lalies MD, Nutt DJ, Pratt JA. Idazoxan-induced reductions in cortical glucose use are accompanied by an increase in noradrenaline release: complementary [14C]2-deoxyglucose and microdialysis studies. Neuropharmacology. 34: 605-13. PMID 7566496 DOI: 10.1016/0028-3908(95)00031-Z  0.317
1993 Laurie DJ, Pratt JA. Flumazenil induces localised increases in glucose utilization during diazepam withdrawal in rats. Brain Research. 631: 277-86. PMID 8131056 DOI: 10.1016/0006-8993(93)91546-5  0.36
1992 Pratt JA. The neuroanatomical basis of anxiety. Pharmacology & Therapeutics. 55: 149-81. PMID 1363249 DOI: 10.1016/0163-7258(92)90014-Q  0.31
1991 Mitchell EA, Pratt JA. Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat. Brain Research. 538: 289-94. PMID 1826459 DOI: 10.1016/0006-8993(91)90442-X  0.322
1991 Brett RR, Pratt JA. Muscimol-associated changes in local cerebral glucose use following chronic diazepam administration. Brain Research. 558: 280-8. PMID 1782545 DOI: 10.1016/0006-8993(91)90779-U  0.351
1989 Laurie DJ, Pratt JA. Local cerebral glucose utilization following subacute and chronic diazepam pretreatment: differential tolerance. Brain Research. 504: 101-11. PMID 2598004 DOI: 10.1016/0006-8993(89)91603-X  0.357
1988 Pratt JA, Laurie DJ, McCulloch J. The effects of FG 7142 upon local cerebral glucose utilization suggest overlap between limbic structures important in anxiety and convulsions. Brain Research. 475: 218-31. PMID 3214732 DOI: 10.1016/0006-8993(88)90610-5  0.324
Show low-probability matches.